Global biologic sales are expected to grow from approximately $325billion in 2020 to $425 billion by 2024 with an estimated compounded annual growth of approximately 7%.*
Biotech drugs, especially monoclonal antibodies (mAbs) and recombinant proteins, allowed the pharmaceutical industry to treat critical and chronic diseases such as osteoporosis, rheumatoid arthritis, and hypercholesterolemia, that were listed as incurable in the past. Biologics are very challenging to stabilize and administrate, especially in a syringe or a drug-delivery device due to their complexity, sensitivity, and viscosity. Moreover, they face stringent regulatory assessment than generics, including the need for clinical trials, which significantly increases costs and timelines to market entry of biosimilar.
Complex drugs and self-administration require an appropriate primary packaging selection from the beginning of the bio drug development process. SG can support biopharma companies in the container closure system choice leveraging its 70-year expertise in drug containment solutions, up to the integration into drug delivery systems, backed up by solid characterization analysis.
Drug containment solutions
Responding to protein-based drug challenges with a new generation of drug containment solutions that enable perfect functionality and integration into drug delivery systems, thus boosting reliability and patient safety.
Contract Manufacturing Services
A broad range of manufacturing services and capabilities to produce high-quality devices able to deliver the latest generation of biodrugs, including large-volume dosage and viscous formulations.
Visual Inspection
Flexible inspection systems based on proven technologies and innovative solutions integrating the latest digital developments to assess these challenging drugs’ integrity and to minimize false rejects.
Assembly lines
State-of-the-art technology for precision assembly solutions. We engineer and manufacture customized solutions for the efficient sub-assembly and final assembly of drug delivery devices, including pen injectors, auto-injectors, wearables, inhalers and nasal sprays.
advanced and integrated solutions from development to production
Other markets we serve
We offer different solutions linked to sublingual and nasal drug administration. Effective, safe, and simple drug delivery guide our R&D in this field.
We provide our clients specializing in diabetes treatment with reliable and effective products, services, and technologies, from ready-to-fill glass cartridges up to user-friendly drug delivery devices.
Prefillable syringes and vials suitable for high-speed, high-volume production. Reliable particle inspection, as well as complementary technologies, such as leak detection to test container integrity.
We have become a key partner for pharmaceutical companies specializing in anticoagulants providing glass syringes, safety systems, and state of the art technologies such as automatic vision inspection and high yield handling systems
We offer different solutions linked to sublingual and nasal drug administration. Effective, safe, and simple drug delivery guide our R&D in this field.
We provide our clients specializing in diabetes treatment with reliable and effective products, services, and technologies, from ready-to-fill glass cartridges up to user-friendly drug delivery devices.
Prefillable syringes and vials suitable for high-speed, high-volume production. Reliable particle inspection, as well as complementary technologies, such as leak detection to test container integrity.
We have become a key partner for pharmaceutical companies specializing in anticoagulants providing glass syringes, safety systems, and state of the art technologies such as automatic vision inspection and high yield handling systems